Such an approach has inherent limitations in reflecting the complexity of the tumor immune microenvironment: firstly, endogenous IFN-γ is predominantly produced by immune cells such as CD56bright NK cells and T lymphocytes, whose spatial distribution and concentration gradients differ significantly from the uniform exogenous IFN-γ applied in vitro.42 Here, IFNG is linked to neoplasm.